Jakub Scaber
Oxford, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Mutant TDP-43 drives impairments in axonal transport and glycolysis in a mouse stem-cell-derived motor neuron model of amyotrophic lateral sclerosis (ALS).
Journal: Cell death & disease
Published: July 02, 2025
Neurodegenerative disease in C9orf72 repeat expansion carriers: population risk and effect of UNC13A.
Journal: Brain : a journal of neurology
Published: March 05, 2025
Drug repurposing in amyotrophic lateral sclerosis (ALS).
Journal: Expert opinion on drug discovery
Published: March 03, 2025
Dynactin-1 mediates rescue of impaired axonal transport due to reduced mitochondrial bioenergetics in amyotrophic lateral sclerosis motor neurons.
Journal: Brain communications
Published: February 13, 2024
Cellular and axonal transport phenotypes due to the C9ORF72 HRE in iPSC motor and sensory neurons.
Journal: Stem cell reports
Published: August 29, 2023
C9orf72-ALS human iPSC microglia are pro-inflammatory and toxic to co-cultured motor neurons via MMP9.
Journal: Nature communications
Published: February 09, 2023
Advantages of routine next-generation sequencing over standard genetic testing in the amyotrophic lateral sclerosis clinic.
Journal: European journal of neurology
Published: September 12, 2022
Human iPSC co-culture model to investigate the interaction between microglia and motor neurons.
Journal: Scientific reports
Published: May 15, 2022
Multicentre appraisal of amyotrophic lateral sclerosis biofluid biomarkers shows primacy of blood neurofilament light chain.
Journal: Brain communications
Published: November 16, 2021
Correction of amyotrophic lateral sclerosis related phenotypes in induced pluripotent stem cell-derived motor neurons carrying a hexanucleotide expansion mutation in C9orf72 by CRISPR/Cas9 genome editing using homology-directed repair.
Journal: Human molecular genetics
Published: January 31, 2020
Last Updated: 09/26/2026